how often to microdose glp 1 Microdosing GLP-1 Why we launched Noom's Microdose

This will ensure that you can use it for the least amount of time possible thereby reducing your risk of negative side effects

Transformative Efficacy : The magnitude of weight loss achieved with GLP-1 agonists, particularly newer agents like tirzepatide, represents an unprecedented pharmacological achievement in obesity treatment

Song et al

the foundation of overall health and wellbeing

Society must be aware of the reality that over 110M patients face today: Medicare is legally prohibited from covering medication to treat obesity Only 18 states cover anti-obesity medications under Medicaid ( detailed analysis of Medicaid coverage from the STOP Obesity Alliance & OAC)